J 104129

Drug Profile

J 104129

Latest Information Update: 08 Aug 2002

Price : $50

At a glance

  • Originator Banyu
  • Class Antiasthmatics; Bronchodilators
  • Mechanism of Action Muscarinic M3 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Bronchitis; Chronic obstructive pulmonary disease

Most Recent Events

  • 08 Aug 2002 No development reported - Preclinical for Chronic obstructive pulmonary disease in Japan (unspecified route)
  • 11 Nov 1999 Preclinical studies have been added to the pharmacodynamics section ,
  • 11 Nov 1999 Preclinical development for Bronchitis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top